Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2021-01-16 2021-01-15
Drug Identification Number 02371022 02371022
Brand name TWYNSTA TWYNSTA
Common or Proper name TWYNSTA 40/5MG 4X7 TWYNSTA 40/5MG 4X7
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients TELMISARTAN AMLODIPINE TELMISARTAN AMLODIPINE
Strength(s) 40MG 5MG 40MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size BLISTER PACK 4X7 BLISTER PACK 4X7
ATC code C09DB C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-01-12 2021-01-12
Actual start date 2021-01-11 2021-01-11
Estimated end date 2021-01-20 2021-01-20
Actual end date 2021-01-15 2021-01-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments